Stockreport

Panbela Announces Pricing of Approximately $9.0 Million Public Offering

Panbela Therapeutics, Inc.  (PBLA) 
PDF MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatmen [Read more]